Effect of the pyrrolopyrimidine lipid peroxidation inhibitor U-101033E on neuronal and astrocytic metabolism and infarct volume in rats with transient middle cerebral artery occlusion

Neurochemistry International

Volumn 50, Issue 7-8, 2007, Pages 932-940

  Haberg A ^a   Qu, H ^a   Hjelstuen, M H ^a   Sonnewald, U ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

Acetate; Astrocytes; Diffusion weighted imaging; Glucose; Ischemia; Lactate; MCAO; Mitochondria; Neurons; Reperfusion

Indexed keywords

6,7,8,9 TETRAHYDRO 9 (2 MORPHOLINOETHYL) 2,4 BIS(1 PYRROLIDINYL) 5H PYRIMIDO[4,5 B]INDOLE; ACETIC ACID; ALANINE; CARBON 13; GLUCOSE; LACTIC ACID; PYRROLOPYRIMIDINE DERIVATIVE; PYRUVATE CARBOXYLASE; PYRUVATE DEHYDROGENASE; PYRUVIC ACID; TISSUE EXTRACT;

ANAEROBIC GLYCOLYSIS; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN INFARCTION SIZE; BRAIN NERVE CELL; BRAIN REGION; CARBON NUCLEAR MAGNETIC RESONANCE; CELL METABOLISM; CONTROLLED STUDY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; DRUG INFUSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISCHEMIA; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION;

ACETATES; ANIMALS; ASTROCYTES; CEREBRAL INFARCTION; DISEASE MODELS, ANIMAL; GLUCOSE; GLYCOLYSIS; LIPID PEROXIDATION; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE CEREBRAL ARTERY; NERVE TISSUE PROTEINS; NEURONS; PYRIMIDINES; PYRROLES; PYRROLIDINES; RATS; RATS, WISTAR;

ANIMALIA; RATTUS;

EID: 34250748907     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2006.12.005     Document Type: Article

References (65)

1. Ankarcrona M., Dypbukt J.M., Bonfoco E., Zhivotovsky B., Orrenius S., Lipton S.A., and Nicotera P. Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 15 4 (1995) 961-973
2. Bogaert Y.E., Rosenthal R.E., and Fiskum G. Postischemic inhibition of cerebral cortex pyruvate dehydrogenase. Free Radic. Biol. Med. 16 (1994) 811-820
3. Bogaert Y.E., Sheu K.F., Hof P.R., Brown A.M., Blass J.P., Rosenthal R.E., and Fiskum G. Neuronal subclass-selective loss of pyruvate dehydrogenase immunoreactivity following canine cardiac arrest and resuscitation. Exp. Neurol. 161 (2000) 115-126
4. Brooks W.M., Stidley C.A., Petropoulos H., Jung R.E., Weers D.C., Friedman S.D., Barlow M.A., Sibbitt Jr. W.L., and Yeo R.A. Metabolic and cognitive response to human traumatic brain injury: a quantitative proton magnetic resonance study. J. Neurotrauma 17 (2000) 629-640
5. Bundy G.L., Ayer D.E., Banitt L.S., Belonga K.L., Mizsak S.A., Palmer J.R., Tustin J.M., Chin J.E., Hall E.D., Linseman K.L., et al. Synthesis of novel 2,4-diaminopyrrolo-[2,3-d]pyrimidines with antioxidant, neuroprotective, and antiasthma activity. J. Med. Chem. 38 21 (1995) 4161-4163
6. Camacho A., and Massieu L. Role of glutamate transporters in the clearance and release of glutamate during ischemia and its relation to neuronal death. Arch. Med. Res. 37 1 (2006) 11-18
7. Christophe M., and Nicolas S. Mitochondria: a target for neuroprotective interventions in cerebral ischemia-reperfusion. Curr. Pharm. Des. 12 6 (2006) 739-757
8. Coyle J.T., and Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 262 5134 (1993) 689-695
9. del Zoppo G.J., Schmid-Schonbein G.W., Mori E., Copeland B.R., and Chang C.M. Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons. Stroke 22 10 (1991) 1276-1283
10. Demougeot C., Marie C., Giroud M., and Beley A. N-Acetylaspartate: a literature review of animal research on brain ischaemia. J. Neurochem. 90 4 (2004) 776-783
11. Denicola A., Freeman B.A., Trujillo M., and Radi R. Peroxynitrite reaction with carbon dioxide/bicarbonate: kinetics and influence on peroxynitrite mediated oxidations. Arch. Biochem. Biophys. 333 (1996) 49-58
12. Dugan L.L., Lin T.S., He Y.Y., Hsu C.Y., and Choi D.W. Detection of free radicals by microdialysis/spin trapping EPR following focal cerebral ischemia-reperfusion and a cautionary note on the stability of 5,5-dimethyl-1-pyrroline N-oxide (DMPO). Free Radic. Res. 23 1 (1995) 27-32
13. Engelhard K., Werner C., Lu H., Mollenberg O., Zieglgansberger W., and Kochs E. The neuroprotective effect of the glutamate antagonist acamprosate following experimental cerebral ischemia A with the lipid peroxidase inhibitor U-101033E. Anaesthesist 49 (2000) 816-821
14. Farooqui A.A., and Horrocks L.A. Lipid peroxides in the free radical pathophysiology of brain diseases. Cell Mol. Neurobiol. 18 6 (1998) 599-608
15. Folbergrova J., Zhao Q., Katsura K., and Siesjö B.K. N-tert-Butylalpha-phenylnitrone improves recovery of brain energy state in rats following transient focal ischemia. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 5057-5061
16. Garcia J.H., Liu K.F., Yoshida Y., Chen S., and Lian J. Brain microvessels: factors altering their patency after the occlusion of a middle cerebral artery (Wistar rat). Am. J. Pathol. 145 3 (1994) 728-740
17. Geddes J.W., and Wood J.D. Changes in the amino acid content of nerve endings (synaptosomes) induced by drugs that alter the metabolism of glutamate and gamma-aminobutyric acid. J. Neurochem. 42 (1984) 16-24
18. 13C NMR spectroscopy: a novel approach to the study of MCA occlusion in rat. J. Cerebr. Blood Flow Metabol. 18 (1998) 1223-1232
19. Håberg A., Qu H., Sæther O., Haraldseth O., Unsgård G., and Sonnewald U. Differences in neurotransmitter synthesis and intermediary metabolism between glutamatergic and GABAergic neurons during 4 h of MCAO in rat. The role of astrocytes in neuronal survival. J. Cerebr. Blood Flow Metabol. 21 (2001) 1451-1463
20. Håberg A., Qu H., and Sonnewald U. Glutamate and GABA metabolism in transient and permanent middle cerebral artery occlusion in rat: importance of astrocytes for neuronal survival. Neurochem. Int. 48 6-7 (2006) 531-540
21. Hall E.D., Andrus P.K., Smith S.L., Oostveen J.A., Scherch H.M., Lutzke B.S., Raub T.J., Sawada G.A., Palmer J.R., Banitt L.S., Tustin J.S., Belonga K.L., Ayer D.E., and Bundy G.L. Neuroprotective efficacy of microvascularly-localized versus brain-penetrating antioxidants. Acta Neurochir. Suppl. 66 (1996) 107-113
22. Hall E.D., Andrus P.K., Smith S.L., Fleck T.J., Scherch H.M., Lutzke B.S., Sawada G.A., Althaus J.S., Vonvoigtlander P.F., Padbury G.E., Larson P.G., Palmer J.R., and Bundy G.L. Pyrrolopyrimidines: novel brain-penetrating antioxidants with neuroprotective activity in brain injury and ischemia models. J. Pharmacol. Exp. Ther. 281 (1997) 895-904
23. Hillered L., and Chan P.H. Brain mitochondrial swelling induced by arachidonic acid and other long chain free fatty acids. J. Neurosci. Res. 24 2 (1989) 247-250
24. Karlsson J., Emgard M., and Brundin P. Comparison between survival of lazaroid-treated embryonic nigral neurons in cell suspension, cultures and transplants. Brain Res. 15 (2002) 268-280
25. Keller J.N., Kindy M.S., Holtsberg F.W., St Clair D.K., Yen H.C., Germeyer A., Steiner S.M., Bruce-Keller A.J., Hutchins J.B., and Mattson M.P. Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction. J. Neurosci. 18 2 (1998) 687-697
26. Kvamme E., Roberg B., and Torgner I.A. Phosphate-activated glutaminase and mitochondrial glutamine transport in the brain. Neurochem. Res. 25 (2000) 1497-1519
27. Lauderback C.M., Breier A.M., Hackett J., Varadarajan S., Goodlett-Mercer J., and Butterfield D.A. The pyrrolopyrimidine U101033E is a potent free radical scavenger and prevents Fe(II)-induced lipid peroxidation in synaptosomal membranes. Biochim. Biophys. Acta 1501 (2000) 149-161
28. Longa E.Z., Weinstein P.R., Carlson S., and Cummins R. Reversible middle cerebral artery occlusion without craniotomy in rats. Stroke 20 (1989) 84-91
29. Maxwell L., and Gavin J. Anti-oxidant therapy improves microvascular ultrastructure and perfusion in postischemic myocardium. Microvasc. Res. 43 (1992) 255-266
30. Müller T.B., Haraldseth O., Jones R.A., Sebastiani G., Godtliebsen F., Lindboe C.F., and Unsgård G. Combined perfusion and diffusion-weighted magnetic resonance imaging in a rat model of reversible cerebral artery occlusion. Stroke 26 (1995) 451-458
31. Müller T.B., Haraldseth O., Jones R.A., Sebastiani G., Godtliebsen F., Lindboe C.F., Unsgård G., and Oksendal A.N. Perfusion and diffusion-weighted MR imaging for in vivo evaluation of treatment with U74389G in a rat stroke model. Stroke 26 (1995) 1453-1458
32. Murakami K., Kondo T., Kawase M., Li Y., Sato S., Chen S.F., and Chan P.H. Mitochondrial susceptibility to oxidative stress exacerbates cerebral infarction that follows permanent focal cerebral ischemia in mutant mice with manganese superoxide dismutase deficiency. J. Neurosci. 18 (1998) 205-213
33. Murin R., Drgova A., Kaplan P., Dobrota D., and Lehotsky J. Ischemia/reperfusion-induced oxidative stress causes structural changes of brain membrane proteins and lipids. Gen. Physiol. Biophys. 20 4 (2001) 431-438
34. Nakai A., Kuroda S., Kristian A., and Siesjö B.K. The immunosuppressant drug FK506 ameliorates secondary mitochondrial dysfunction following transient focal cerebral ischemia in the rat. Neurobiol. Dis. 4 (1997) 288-300
35. Norenberg M.D., and Martinez-Hernandez A. Fine structural localization of glutamine synthetase in astrocytes of rat brain. Brain Res. 161 (1979) 303-310
36. 2 fixation increases with brain activity. J. Neurosci. 24 50 (2004) 11273-11279
37. 2-fixing enzymes in the metabolism of rat brain. J. Neurochem. 22 (1974) 717-724
38. Piantadosi C.A., and Zhang J. Mitochondrial generation of reactive oxygen species after brain ischemia in the rat. Stroke 27 (1996) 327-331 (discussion 332)
39. 13C MR spectroscopy study of lactate as substrate for rat brain. Dev. Neurosci. 22 (2000) 429-436
40. Radi R., Cassina A., Hodara R., Quijano C., and Castro L. Peroxynitrite reactions and formation in mitochondria. Free Radic. Biol. Med. 33 (2002) 1451-1464
41. Rohn T.T., Nelson L.K., Waeg G., and Quinn M.T. U-101033E (2,4-diaminopyrrolopyrimidine), a potent inhibitor of membrane lipid peroxidation as assessed by production of hydroxynonenal, malondialdehyde, and 4-hydroxynonenal-protein adducts. Biochem. Pharmacol. 56 (1998) 1371-1379
42. Schmid-Elsaesser R., Zausinger S., Hungerhuber E., Plesnila N., Baethmann A., and Reulen H.-J. Superior neuroprotective efficacy of a novel antioxidant (U-10133E) with improved blood-brain barrier permeability in cerebral ischemia. Stroke 28 (1997) 2018-2024
43. Schmid-Elsaesser R., Zausinger S., Hungerhuber E., Baethmann A., and Reulen H.-J. Neuroprotective properties of a novel antioxidant (U-10133E) with improved blood-brain barrier permeability in focal cerebral ischemia. Acta Neurochir. Suppl. 70 (1997) 176-178
44. Schmid-Elsaesser R., Zausinger S., Hungerhuber E., Plesnila N., Baethmann A., and Reulen H.-J. Neuroprotective efficacy of combination therapy with two different antioxidants in rats subjected to transient focal ischemia. Brain Res. 816 (1998) 471-479
45. Schmid-Elsaesser R., Hungerhuber E., Zausinger S., Baethmann A., and Reulen H.-J. Neuroprotective effects of the novel brain-penetrating antioxidant U-101033E and the spin-trapping agent alpha-phenyl-N-tert-nitrone (PNB). Exp. Brain Res. 130 (2000) 60-66
46. Schurr A., Payne R.S., Miller J.J., and Rigor B.M. Glia are the main source of lactate utilized by neurons for recovery of function posthypoxia. Brain Res. 7 (1997) 221-224
47. Schurr A., Payne R.S., Miller J.J., and Rigor B.M. Brain lactate is an obligatory aerobic energy substrate for functional recovery after hypoxia: further in vitro validation. J. Neurochem. 69 1 (1997) 423-426
48. Siesjö B., Agardh C.-D., and Bengtsson F. Free radicals and brain damage. Cerebrovasc. Brain Metabol. Rev. 1 (1989) 165-211
49. Sims N.R., and Anderson M.F. Mitochondrial contributions to tissue damage in stroke. Neurochem. Int. 40 (2002) 511-526
50. 13C NMR spectroscopy of cultured neurons and astrocytes. Neurosci. Lett. 128 (1991) 235-239
51. 13C NMR studies. J. Neurochem. 67 (1996) 1711-1717
52. Starkov A.A., Fiskum G., Chinopoulos C., Lorenzo B.J., Browne S.E., Patel M.S., and Beal M.F. Mitochondrial alpha-ketoglutarate dehydrogenase complex generates reactive oxygen species. J. Neurosci. 24 (2004) 7779-7788
53. Tirilazad International Steering Committee. Tirilazad mesylate in acute ischemic stroke. A systematic review. Stroke 32 (2000) 2257-2265
54. Tretter L., and Adam-Vizi V. Generation of reactive oxygen species in the reaction catalyzed by alpha-ketoglutarate dehydrogenase. J. Neurosci. 24 (2004) 7771-7778
55. Urenjak J., Williams S.R., Gadian D.G., and Noble M. Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro. J. Neurochem. 59 1 (1992) 55-61
56. Van den Berg C.J. A model of compartmentation in the mouse brain based on glucose and acetate metabolism. In: Balaz R., and Cremer J.E. (Eds). Metabolic Compartmentation in the Brain (1973), Macmillan Press, London 137-166
57. Wang Y.H., Wang W.Y., Chang C.C., Liou K.T., Sung Y.J., Liao J.F., Chen C.F., Chang S., Hou Y.C., Chou Y.C., and Shen Y.C. Taxifolin ameliorates cerebral ischemia-reperfusion injury in rats through its anti-oxidative effect and modulation of NF-kappa B activation. J. Biomed. Sci. 13 1 (2006) 127-141
58. Waniewski R.A., and Martin D.L. Preferential utilization of acetate by astrocytes is attributable to transport. J. Neurosci. 18 14 (1998) 5225-5233
59. Ward B.J., and Scoote M. Antioxidants attenuate postischemic endothelial cell swelling and luminal membrane blebbing in cardiac capillaries. Microvasc. Res. 53 (1997) 179-186
60. White B.C., Sullivan J.M., DeGracia D.J., O'Neil B.J., Neumar R.W., Grossman L.I., Rafols J.A., and Krause G.S. Brain ischemia and reperfusion: molecular mechanisms of neuronal injury. J. Neurol. Sci. 179 S 1-2 (2000) 1-33
61. Won S.J., Kim D.Y., and Gwag B.J. Cellular and molecular pathways of ischemic neuronal death. J. Biochem. Mol. Biol. 35 1 (2002) 67-86
62. Xiong Y., Peterson P.L., Muizeelar J.P., and Lee C.P. Amelioration of mitochondrial function by a novel antioxidant U-101033E following traumatic brain injury in rats. J. Neurotrauma 14 (1997) 907-917
63. Xiong Y., Peterson P.L., Verweij B.H., Muizeelar J.P., and Lee C.P. Mitochondrial dysfunction after experimental traumatic brain injury: combined efficacy of SNX-11 and U-101033E. J. Neurotrauma 15 (1998) 531-544
64. Yu A.C.H., Drejer J., Hertz L., and Schousboe A. Pyruvate carboxylase activity in primary cultures of astrocytes and neurons. J. Neurochem. 41 (1983) 1484-1487
65. Zaidan E., Sheu K.F., and Sims N.R. The pyruvate dehydrogenase complex is partially inactivated during early recirculation following short-term forebrain ischemia in rats. J. Neurochem. 70 (1998) 233-241